Adjuvant therapy of pancreatic cancer.

Published

Journal Article (Review)

Of the 33,370 patients diagnosed with pancreatic carcinoma in the United States this year, approximately 20% will present with resectable disease. At present, surgery offers the only means of cure. Radiation therapy and chemotherapy approaches have been used to enhance local and systemic control and survival. Phase III trials evaluating these modalities have led to conflicting results, leading to controversy in the use and selection of therapy. Phase II studies are now being conducted to evaluate target agent therapy with chemoradiation.

Full Text

Duke Authors

Cited Authors

  • Willett, CG; Czito, BG; Bendell, JC

Published Date

  • May 2007

Published In

Volume / Issue

  • 13 / 3

Start / End Page

  • 185 - 191

PubMed ID

  • 17620768

Pubmed Central ID

  • 17620768

International Standard Serial Number (ISSN)

  • 1528-9117

Digital Object Identifier (DOI)

  • 10.1097/PPO.0b013e318074e071

Language

  • eng

Conference Location

  • United States